thrombin receptor peptide sfllrnp has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M | 1 |
| Bassus, S; Franz, N; Graff, J; Harder, S; Kirchmaier, CM; Klinkhardt, U; Schini-Kerth, VB | 1 |
2 other study(ies) available for thrombin receptor peptide sfllrnp and Diabetes Mellitus
| Article | Year |
|---|---|
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Collagen Type I; Diabetes Mellitus; Drug Resistance; Drug Therapy, Combination; Epinephrine; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Vasoconstrictor Agents | 2006 |
Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Blood Platelets; Clopidogrel; Cytoplasmic Granules; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Male; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet-Derived Growth Factor; Ticlopidine | 2002 |